Title: Ulf Brasen - Innovator in Dextran Sulfate Development
Introduction
Ulf Brasen is a notable inventor based in Sweden, recognized for his contributions to the field of biochemistry. He has developed a new dextran sulfate that exhibits improved biological effects and reduced toxicity compared to existing products on the market. His innovative approach has the potential to impact various medical applications.
Latest Patents
Ulf Brasen holds a patent for a novel dextran sulfate, which is characterized by a number average molecular weight (Mn) ranging from 1850 to 3500 Da. This dextran sulfate, or its salt, features an average sulfate number per glucose unit between 2.5 and 3.0. Additionally, the average sulfation of the C2 position in the glucose units is at least 90%. These unique properties contribute to the dextran sulfate's enhanced biological effects.
Career Highlights
Ulf Brasen is currently associated with Tx Medic AB, where he continues to advance his research and development efforts. His work focuses on creating innovative solutions that address the limitations of existing dextran sulfate molecules. Despite having no patents listed under his name, his contributions to the field are significant.
Collaborations
Ulf collaborates with notable colleagues, including Lars M Bruce and Lars Bruce, who share his commitment to advancing biochemistry and medical research.
Conclusion
Ulf Brasen's work in developing a new dextran sulfate showcases his innovative spirit and dedication to improving medical solutions. His contributions are poised to make a meaningful impact in the field of biochemistry.